157 related articles for article (PubMed ID: 23617586)
21. Association of a common variant in TCF7L2 gene with type 2 diabetes mellitus in a Persian population.
Palizban A; Nikpour M; Salehi R; Maracy MR
Clin Exp Med; 2012 Jun; 12(2):115-9. PubMed ID: 21678030
[TBL] [Abstract][Full Text] [Related]
22. TCF7L2 type 2 diabetes risk variant, lifestyle factors, and incidence of prostate cancer.
Drake I; Wallström P; Hindy G; Ericson U; Gullberg B; Bjartell A; Sonestedt E; Orho-Melander M; Wirfält E
Prostate; 2014 Sep; 74(12):1161-70. PubMed ID: 24961829
[TBL] [Abstract][Full Text] [Related]
23. An alternative polyadenylation signal in TCF7L2 generates isoforms that inhibit T cell factor/lymphoid-enhancer factor (TCF/LEF)-dependent target genes.
Locke JM; Da Silva Xavier G; Rutter GA; Harries LW
Diabetologia; 2011 Dec; 54(12):3078-82. PubMed ID: 21913056
[TBL] [Abstract][Full Text] [Related]
24. TCF7L2 rs7903146 impairs islet function and morphology in non-diabetic individuals.
Le Bacquer O; Kerr-Conte J; Gargani S; Delalleau N; Huyvaert M; Gmyr V; Froguel P; Neve B; Pattou F
Diabetologia; 2012 Oct; 55(10):2677-2681. PubMed ID: 22911383
[TBL] [Abstract][Full Text] [Related]
25. Alternative splicing of TCF7L2 gene in omental and subcutaneous adipose tissue and risk of type 2 diabetes.
Prokunina-Olsson L; Kaplan LM; Schadt EE; Collins FS
PLoS One; 2009 Sep; 4(9):e7231. PubMed ID: 19789636
[TBL] [Abstract][Full Text] [Related]
26. Transcription factor 7-like 2 (TCF7L2) gene polymorphisms are strong predictorsof type 2 diabetes among nonobese diabetics in the Turkish population.
Erkoç Kaya D; Arikoğlu H; Kayiş SA; Öztürk O; Gönen MS
Turk J Med Sci; 2017 Feb; 47(1):22-28. PubMed ID: 28263491
[TBL] [Abstract][Full Text] [Related]
27.
Srinivasan S; Kaur V; Chamarthi B; Littleton KR; Chen L; Manning AK; Merino J; Thomas MK; Hudson M; Goldfine A; Florez JC
Diabetes Care; 2018 Mar; 41(3):554-561. PubMed ID: 29326107
[TBL] [Abstract][Full Text] [Related]
28. Rare intronic variants of TCF7L2 arising by selective sweeps in an indigenous population from Mexico.
Acosta JL; Hernández-Mondragón AC; Correa-Acosta LC; Cazañas-Padilla SN; Chávez-Florencio B; Ramírez-Vega EY; Monge-Cázares T; Aguilar-Salinas CA; Tusié-Luna T; Del Bosque-Plata L
BMC Genet; 2016 May; 17(1):68. PubMed ID: 27230431
[TBL] [Abstract][Full Text] [Related]
29. The Diabetes Gene and Wnt Pathway Effector TCF7L2 Regulates Adipocyte Development and Function.
Chen X; Ayala I; Shannon C; Fourcaudot M; Acharya NK; Jenkinson CP; Heikkinen S; Norton L
Diabetes; 2018 Apr; 67(4):554-568. PubMed ID: 29317436
[TBL] [Abstract][Full Text] [Related]
30. Effects of TCF7L2 rs7903146 variant on metformin response in patients with type 2 diabetes.
Dujic T; Bego T; Malenica M; Velija-Asimi Z; Ahlqvist E; Groop L; Pearson ER; Causevic A; Semiz S
Bosn J Basic Med Sci; 2019 Nov; 19(4):368-374. PubMed ID: 31070566
[TBL] [Abstract][Full Text] [Related]
31. Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism.
Savic D; Ye H; Aneas I; Park SY; Bell GI; Nobrega MA
Genome Res; 2011 Sep; 21(9):1417-25. PubMed ID: 21673050
[TBL] [Abstract][Full Text] [Related]
32. KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment.
Song J; Yang Y; Mauvais-Jarvis F; Wang YP; Niu T
BMC Med Genet; 2017 Jun; 18(1):64. PubMed ID: 28587604
[TBL] [Abstract][Full Text] [Related]
33. Impact of KCNQ1, CDKN2A/2B, CDKAL1, HHEX, MTNR1B, SLC30A8, TCF7L2, and UBE2E2 on risk of developing type 2 diabetes in Thai population.
Plengvidhya N; Chanprasert C; Chongjaroen N; Yenchitsomanus PT; Homsanit M; Tangjittipokin W
BMC Med Genet; 2018 Jun; 19(1):93. PubMed ID: 29871606
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
Lyssenko V; Lupi R; Marchetti P; Del Guerra S; Orho-Melander M; Almgren P; Sjögren M; Ling C; Eriksson KF; Lethagen AL; Mancarella R; Berglund G; Tuomi T; Nilsson P; Del Prato S; Groop L
J Clin Invest; 2007 Aug; 117(8):2155-63. PubMed ID: 17671651
[TBL] [Abstract][Full Text] [Related]
35. TCF7L2 rs7903146 polymorphism is associated with gastric cancer: A case-control study in the Venezuelan population.
Torres K; Labrador L; Valderrama E; Chiurillo MA
World J Gastroenterol; 2016 Jul; 22(28):6520-6. PubMed ID: 27605886
[TBL] [Abstract][Full Text] [Related]
36. Association of rs7903146, rs12255372, and rs290487 polymorphisms in TCF7L2 gene with type 2 diabetes in an Iranian Kurdish ethnic group.
Shokouhi S; Delpisheh A; Haghani K; Mahdizadeh M; Bakhtiyari S
Clin Lab; 2014; 60(8):1269-76. PubMed ID: 25185411
[TBL] [Abstract][Full Text] [Related]
37. The broad pathogenetic role of TCF7L2 in human diseases beyond type 2 diabetes.
Del Bosque-Plata L; Hernández-Cortés EP; Gragnoli C
J Cell Physiol; 2022 Jan; 237(1):301-312. PubMed ID: 34612510
[TBL] [Abstract][Full Text] [Related]
38. Association of the rs7903146 single nucleotide polymorphism at the Transcription Factor 7-like 2 (TCF7L2) locus with type 2 diabetes in Brazilian subjects.
Barra GB; Dutra LA; Watanabe SC; Costa PG; Cruz PS; Azevedo MF; Amato AA
Arq Bras Endocrinol Metabol; 2012 Nov; 56(8):479-84. PubMed ID: 23295285
[TBL] [Abstract][Full Text] [Related]
39. The rs7903146 Variant in the
Cropano C; Santoro N; Groop L; Dalla Man C; Cobelli C; Galderisi A; Kursawe R; Pierpont B; Goffredo M; Caprio S
Diabetes Care; 2017 Aug; 40(8):1082-1089. PubMed ID: 28611053
[TBL] [Abstract][Full Text] [Related]
40. Genotypes of HLA, TCF7L2, and FTO as potential modifiers of the association between sweetened beverage consumption and risk of LADA and type 2 diabetes.
Löfvenborg JE; Ahlqvist E; Alfredsson L; Andersson T; Dorkhan M; Groop L; Tuomi T; Wolk A; Carlsson S
Eur J Nutr; 2020 Feb; 59(1):127-135. PubMed ID: 30656477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
